SCHEMBL4127583

SCHEMBL4127583

COCOc1cccc(C(C)=O)c1OCOC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.55
LMNA P02545 6/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
CHEK1 O14757 1/20 0.40
AURKA O14965 1/20 0.40
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
ABL1 P00519 1/20 0.40
NTRK1 P04629 1/20 0.40
FYN P06241 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
IGF1R P08069 1/20 0.40
MET P08581 1/20 0.40
PDGFRB P09619 1/20 0.40
PIM1 P11309 1/20 0.40
FGFR1 P11362 1/20 0.40
PRKACA P17612 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16416495 0.87 PTPN1 (0.51) PTPN1KDM4EALDH1A1CHEK1AURKA
SCHEMBL28285304 0.85 CHEK1 (0.51) PTPN1LMNAKDM4EALDH1A1CHEK1
SCHEMBL2047902 0.84 LMNA (0.64) PTPN1LMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL31444062 0.83 PTPN1 (0.48) PTPN1LMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL2220154 0.80 PTPN1 (0.51) PTPN1LMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL690705 0.79 CYP3A4 (0.53) LMNASMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL24446268 0.79 PTPN1 (0.53) PTPN1LMNASMN1; SMN2KDM4EALDH1A1
SCHEMBL8481540 0.79 PTPN1 (0.50) PTPN1SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL18662462 0.79 MAPT (0.44) PTPN1LMNASMN1; SMN2MAPTL3MBTL1
SCHEMBL29996307 0.79 MAPT (0.44) PTPN1LMNASMN1; SMN2MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 PTPN1 3602/4885LMNA 3162/4885SMN1; SMN2 3331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.